KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Other Non-Current Liabilities (2016 - 2025)

Rigel Pharmaceuticals (RIGL) has 16 years of Other Non-Current Liabilities data on record, last reported at $40.0 million in Q1 2025.

  • For Q1 2025, Other Non-Current Liabilities changed 0.0% year-over-year to $40.0 million; the TTM value through Mar 2025 reached $40.0 million, changed 0.0%, while the annual FY2024 figure was $5.0 million, 87.48% down from the prior year.
  • Other Non-Current Liabilities reached $40.0 million in Q1 2025 per RIGL's latest filing, up from $5.0 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $57.5 million in Q1 2021 and bottomed at $5.0 million in Q4 2024.
  • Average Other Non-Current Liabilities over 5 years is $43.0 million, with a median of $42.1 million recorded in 2023.
  • Peak YoY movement for Other Non-Current Liabilities: skyrocketed 1050.66% in 2021, then crashed 87.48% in 2024.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $52.7 million in 2021, then decreased by 19.84% to $42.3 million in 2022, then decreased by 5.49% to $39.9 million in 2023, then plummeted by 87.48% to $5.0 million in 2024, then skyrocketed by 699.62% to $40.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $40.0 million in Q1 2025, $5.0 million in Q4 2024, and $40.0 million in Q3 2024.